Podcast Episodes

Back to Search
Fixing failed spray-dried formulations faster (Sponsored)
Fixing failed spray-dried formulations faster (Sponsored)

Spray-dried dispersions are widely used, but they do not always deliver expected results. In this sponsored episode of The Top Line, host Stephanie B…

2 months, 2 weeks ago

Short Long
View Episode
Roivant’s CEO thinks China is a ‘red herring’
Roivant’s CEO thinks China is a ‘red herring’

China’s biotech rise has been a persistent concern for federal health leaders, Congress, and many biopharma executives. But to Roivant CEO Matt Gline…

2 months, 3 weeks ago

Short Long
View Episode
The top 10 pharma R&D budgets of 2025
The top 10 pharma R&D budgets of 2025

The wait is over. Fierce Biotech has released its annual ranking of the top 10 pharma R&D budgets of 2025—offering a clear look at which companies ar…

3 months ago

Short Long
View Episode
An update on the pharma industry’s reshoring effort
An update on the pharma industry’s reshoring effort

After a wave of high-profile pledges to bring pharmaceutical manufacturing back to the United States, a clearer picture of what reshoring actually lo…

3 months, 1 week ago

Short Long
View Episode
Pulse check on Lilly's GLP-1 fortunes
Pulse check on Lilly's GLP-1 fortunes

While Lilly’s position in the obesity market and wider GLP-1 space has remained largely unshakeable in recent months, a crack in the company’s armor …

3 months, 1 week ago

Short Long
View Episode
Avoiding 11th hour surprises in clinical trials (Sponsored)
Avoiding 11th hour surprises in clinical trials (Sponsored)

In this episode of The Top Line, host Chris Hayden speaks with Olive McCormick, Head of Quality and Qualified Person at Almac Clinical Services about…

3 months, 2 weeks ago

Short Long
View Episode
What Xaira is building after its $1B fundraise
What Xaira is building after its $1B fundraise

Since Xaira’s eye-popping $1 billion fundraise in 2024, the company has said relatively little in public. That’s made it one of biotech’s more closel…

3 months, 2 weeks ago

Short Long
View Episode
Patent expirations push biopharma industry toward a tougher 2026
Patent expirations push biopharma industry toward a tougher 2026

In this week’s episode of “The Top Line,” we take a deep dive into the fourth-quarter performance of the biopharma industry and how the sector fared …

3 months, 3 weeks ago

Short Long
View Episode
As AI evolves, the modern R&D lab is changing
As AI evolves, the modern R&D lab is changing

The design of the modern R&D lab may be due for a rethink.

Artificial intelligence and automation are reshaping how science gets done, yet many of th…

4 months ago

Short Long
View Episode
How physiology powers biotech innovation (Sponsored)
How physiology powers biotech innovation (Sponsored)

Physiology connects genes and molecules to whole-body function, shaping every stage of drug discovery and development. In this sponsored episode of T…

4 months, 1 week ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us